Humana and PQS are piloting the first diabetes outcomes-based program within the EQuIPP® platform that incentivizes improvement across unique diabetes control measures
DURHAM, N.C.--Pharmacy Quality Solutions (PQS), the leading technology provider of pharmacy performance management services, and leading health and well-being company, Humana (NYSE: HUM), have partnered on a new diabetes outcomes-based pilot program that will be hosted within PQS’s EQuIPP® platform. Humana will be incentivizing pharmacies to improve patient outcomes for specific diabetes quality measures in this first-of-its-kind program using EQuIPP®.
Select pharmacies in Iowa, Kentucky, North Carolina, Ohio, Arizona, and Texas, serving Humana Medicare Advantage members with a prescription drug benefit, will be able to track the performance of their patients through the following quality measures: Diabetes Control - A1c Testing and Diabetes Control - A1c Under Control through the 2020 program year. For pharmacies, higher performance scores will correspond to greater incentives.
“We recognize the important role pharmacists play in helping patients manage their diabetes, and we designed this innovative program to reward pharmacies for these positive outcomes,” says Michael Taday, Vice President of Humana’s Pharmacy Clinical Strategies and Operations. “Humana’s focus on value-based care creates opportunities for pharmacists to expand their scope of work and impact patient outcomes in a holistic approach.”
“We couldn’t be more excited to work with Humana on this next chapter of quality measurement use for pharmacy providers,” says Emily Endres, PQS VP of Client Services. “The PQS dashboard will provide transparent data for pilot stores that will allow the provider to have a holistic view of lab values, testing information and a full set of resources that will walk the pharmacy through a diabetes management process through the use of quality measurement, each step of the way.”
As a part of this 854-store pilot program, documentation provided by the pharmacy that captures patient encounters will be used to understand the impact pharmacists have on improving diabetes care.
“This A1c program will show how EQuIPP® shares data between participating pharmacies and Humana to increase positive outcomes for patients with diabetes,” says PQS Chief Executive Officer Jeff Newell, RPh. “PQS and Humana are focused on collaborating with pharmacists to expand outcomes-based solutions. As the neutral intermediary between health plans and providers, PQS enables actionable data to drive quality improvement. We look forward to expanding this pilot more broadly with other disease states in the future.”
About Pharmacy Quality Solutions, Inc.
Pharmacy Quality Solutions (PQS), is the leading provider of performance management services representing nearly 90% of Medicare lives and 95% of community pharmacies. PQS delivers the quality insights and guidance necessary to support its customers’ efforts to optimize the quality of medication management and use for their Medicare, Medicaid and commercial populations. PQS connects medication use stakeholders to actionable, quality information in a consistent and reliable fashion, allowing them to move more quickly from measurement to improvement. Its industry-leading platform, EQuIPP®, provides dependable measurement and reporting on key medication use quality measures, including addressing medication adherence, gaps in care, and patient safety. PQS provides measurement insights that are timely, actionable, and simply understood. For more information, please visit www.pharmacyquality.com.
David Simoneaux, 919.864.9756 ext. 312